INSPECS Group Past Earnings Performance
Past criteria checks 0/6
INSPECS Group's earnings have been declining at an average annual rate of -37.3%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 37.1% per year.
Key information
-37.3%
Earnings growth rate
-94.0%
EPS growth rate
Medical Equipment Industry Growth | -9.5% |
Revenue growth rate | 37.1% |
Return on equity | -1.0% |
Net Margin | -0.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
INSPECS Group plc's (LON:SPEC) Shares Lagging The Industry But So Is The Business
Jan 18A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)
Oct 30A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)
May 23Returns On Capital At INSPECS Group (LON:SPEC) Paint A Concerning Picture
Mar 04A Look At The Fair Value Of INSPECS Group plc (LON:SPEC)
Feb 01INSPECS Group (LON:SPEC) Has A Pretty Healthy Balance Sheet
Dec 06INSPECS Group (LON:SPEC) Might Be Having Difficulty Using Its Capital Effectively
Nov 01Estimating The Intrinsic Value Of INSPECS Group plc (LON:SPEC)
Aug 13Is It Time To Consider Buying Inspecs Group plc (LON:SPEC)?
Jun 23Calculating The Fair Value Of Inspecs Group plc (LON:SPEC)
May 10The Inspecs Group (LON:SPEC) Share Price Is Up 92% And Shareholders Are Holding On
Mar 16What Type Of Shareholders Own The Most Number of Inspecs Group plc (LON:SPEC) Shares?
Feb 09A Look At The Fair Value Of Inspecs Group plc (LON:SPEC)
Dec 17Revenue & Expenses BreakdownBeta
How INSPECS Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 203 | -1 | 101 | 0 |
30 Sep 23 | 205 | -1 | 102 | 0 |
30 Jun 23 | 202 | -1 | 101 | 0 |
31 Mar 23 | 204 | -4 | 102 | 0 |
31 Dec 22 | 201 | -6 | 100 | 0 |
30 Sep 22 | 207 | -5 | 102 | 0 |
30 Jun 22 | 204 | -4 | 100 | 0 |
31 Mar 22 | 192 | -4 | 91 | 0 |
31 Dec 21 | 182 | -4 | 84 | 0 |
30 Sep 21 | 149 | -4 | 67 | 0 |
30 Jun 21 | 113 | -4 | 49 | 0 |
31 Mar 21 | 74 | -5 | 33 | 0 |
31 Dec 20 | 35 | -7 | 17 | 0 |
30 Sep 20 | 37 | -6 | 17 | 0 |
30 Jun 20 | 38 | -5 | 16 | 0 |
31 Mar 20 | 44 | 0 | 16 | 0 |
31 Dec 19 | 46 | 5 | 15 | 0 |
30 Sep 19 | 50 | 6 | 15 | 0 |
30 Jun 19 | 48 | 6 | 14 | 0 |
31 Mar 19 | 45 | 4 | 13 | 0 |
31 Dec 18 | 45 | 3 | 13 | 0 |
31 Dec 17 | 36 | -2 | 14 | 0 |
31 Dec 16 | 18 | 1 | 6 | 0 |
Quality Earnings: SPEC is currently unprofitable.
Growing Profit Margin: SPEC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SPEC is unprofitable, and losses have increased over the past 5 years at a rate of 37.3% per year.
Accelerating Growth: Unable to compare SPEC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPEC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).
Return on Equity
High ROE: SPEC has a negative Return on Equity (-0.96%), as it is currently unprofitable.